UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Determining True HER2 Gene Status in Breast Cancers With Polysomy by Using Alternative Chromosome 17 Reference Genes: Implications for Anti-HER2 Targeted Therapy

Journal of clinical oncology, 2011-11, Vol.29 (31), p.4168-4174

2011

Volltextzugriff (PDF)

Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31

JNCI : Journal of the National Cancer Institute, 2013-12, Vol.105 (23), p.1782-1788

2013

Volltextzugriff (PDF)

Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories

Journal of clinical oncology, 2010-10, Vol.28 (28), p.4300-4306

2010

Volltextzugriff (PDF)

Immunohistochemical Detection Using the New Rabbit Monoclonal Antibody SP1 of Estrogen Receptor in Breast Cancer Is Superior to Mouse Monoclonal Antibody 1D5 in Predicting Survival

Journal of clinical oncology, 2006-12, Vol.24 (36), p.5637-5644

2006

Volltextzugriff (PDF)

HER-2 testing in breast cancer using parallel tissue-based methods

JAMA : the journal of the American Medical Association, 2004-04, Vol.291 (16), p.1972

2004

Volltextzugriff (PDF)

One year of sitagliptin treatment protects against islet amyloid-associated β-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice

American journal of physiology: endocrinology and metabolism, 2013-08, Vol.305 (4), p.E475-E484

2013

Volltextzugriff (PDF)

High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system

Modern pathology, 2008-10, Vol.21 (10), p.1271-1277

2008

Volltextzugriff (PDF)

Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases

Breast cancer research and treatment, 2008-08, Vol.110 (3), p.417-426

2008

Volltextzugriff (PDF)

Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen

Cancer Immunology, Immunotherapy, 2012-06, Vol.61 (6), p.771-782

2012

Volltextzugriff (PDF)

The knowns and the unknowns in HER2 testing in breast cancer

American journal of clinical pathology, 2011-07, Vol.136 (1), p.5-6

2011

Volltextzugriff (PDF)

Concordance between human epidermal growth factor receptor 2 testing by reverse transcriptase polymerase chain reaction and fluorescent in situ hybridization

Journal of clinical oncology, 2012-05, Vol.30 (14), p.1726-1727

2012

Volltextzugriff (PDF)

Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients

The American journal of surgical pathology, 2009-12, Vol.33 (12), p.1802-1808

2009

Volltextzugriff (PDF)

HER2 in well differentiated breast cancer: is testing necessary?

Breast cancer research and treatment, 2008-12, Vol.112 (3), p.551-556

2008

Volltextzugriff (PDF)

Reply to Hanna et al

Modern pathology, 2008-10, Vol.21 (10), p.1280-1281

2008

Volltextzugriff (PDF)

Positive response to neoadjuvant cyclophosphamide and doxorubicin in topoisomerase II nonamplified/HER2/neu negative/polysomy 17 absent breast cancer patients

Cancer management and research, 2010-08, Vol.2 (default), p.213-218

2010

Volltextzugriff (PDF)

One year of sitagliptin treatment protects against islet amyloid-associated [Beta]-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice

American journal of physiology: endocrinology and metabolism, 2013-08, Vol.305 (4), p.E475

2013

Volltextzugriff (PDF)

Predicting Degree of Benefit From AdjuvantTrastuzumab in NSABP Trial B-31

JNCI : Journal of the National Cancer Institute, 2013-12, Vol.105 (23), p.1782

2013

Volltextzugriff (PDF)

Monoclonal Antibodies for Diagnosis of Infectious Diseases in Humans

Science (American Association for the Advancement of Science), 1983-02, Vol.219 (4585), p.637-644

1983

Volltextzugriff (PDF)

Positive response to neoadjuvant cyclophosphamide and doxorubicin in topoisomerase II nonamplified/HER2/neu negative/polysomy 17 absent breast cancer patients

Cancer management and research, 2010-08, Vol.2, p.213-218

2010

Volltextzugriff (PDF)

Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia

Infection and Immunity, 1982-10, Vol.38 (1), p.273-281

1982

Volltextzugriff (PDF)

Monoclonal antibodies to herpes simplex viruses: use in antigenic typing and rapid diagnosis

The Journal of infectious diseases, 1983-05, Vol.147 (5), p.829-837

1983

Volltextzugriff (PDF)

Rapid diagnosis of cytomegaloviral pneumonia by tissue immunofluorescence with a murine monoclonal antibody

The Journal of infectious diseases, 1985-02, Vol.151 (2), p.325-329

1985

Volltextzugriff (PDF)

Herpesvirus-Specific RNA and Protein in Carcinoma of the Uterine Cervix

Proceedings of the National Academy of Sciences - PNAS, 1982-06, Vol.79 (12), p.3853-3857

1982

Volltextzugriff (PDF)

Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatment

Biology of blood and marrow transplantation, 1997-12, Vol.3 (6), p.316-323

1997

Volltextzugriff (PDF)

Monoclonal Antibodies for the Diagnosis of Sexually Transmitted Diseases

Clinics in laboratory medicine, 1985-09, Vol.5 (3), p.575-588

1985

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Englisch
(141)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Determining True HER2 Gene Status in Breast Cancers With Polysomy by Using Alternative Chromosome 17 Reference Genes: Implications for Anti-HER2 Targeted Therapy

Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31

Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories

Immunohistochemical Detection Using the New Rabbit Monoclonal Antibody SP1 of Estrogen Receptor in Breast Cancer Is Superior to Mouse Monoclonal Antibody 1D5 in Predicting Survival

HER-2 testing in breast cancer using parallel tissue-based methods

One year of sitagliptin treatment protects against islet amyloid-associated β-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice

High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system

Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases

Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimen

The knowns and the unknowns in HER2 testing in breast cancer

Concordance between human epidermal growth factor receptor 2 testing by reverse transcriptase polymerase chain reaction and fluorescent in situ hybridization

Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients

HER2 in well differentiated breast cancer: is testing necessary?

Reply to Hanna et al

Positive response to neoadjuvant cyclophosphamide and doxorubicin in topoisomerase II nonamplified/HER2/neu negative/polysomy 17 absent breast cancer patients

One year of sitagliptin treatment protects against islet amyloid-associated [Beta]-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice

Predicting Degree of Benefit From AdjuvantTrastuzumab in NSABP Trial B-31

Monoclonal Antibodies for Diagnosis of Infectious Diseases in Humans

Positive response to neoadjuvant cyclophosphamide and doxorubicin in topoisomerase II nonamplified/HER2/neu negative/polysomy 17 absent breast cancer patients

Monoclonal antibodies to cytomegalovirus: rapid identification of clinical isolates and preliminary use in diagnosis of cytomegalovirus pneumonia

Monoclonal antibodies to herpes simplex viruses: use in antigenic typing and rapid diagnosis

Rapid diagnosis of cytomegaloviral pneumonia by tissue immunofluorescence with a murine monoclonal antibody

Herpesvirus-Specific RNA and Protein in Carcinoma of the Uterine Cervix

Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatment

Monoclonal Antibodies for the Diagnosis of Sexually Transmitted Diseases

Suchergebnisse filtern